ArticleBlood advances2022
Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity.
Ipsita Pal, Andre M Sardinha Grilo, Alec Gaspary, Sohani Das Sharma, Luigi Scotto, Owen A O'Connor, Marko Jovanovic, Changchun Deng, Luke E Berchowitz
Open access · goldAbstract read
In one paragraphArticle in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 3 institutions in 1 country.
Ipsita PalCenter for Lymphoid Malignancies, Department of Medicine and.
Andre M Sardinha GriloCenter for Lymphoid Malignancies, Department of Medicine and.
Alec GasparyDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY.
Sohani Das SharmaDepartment of Biological Sciences, Columbia University, New York, NY.
Luigi ScottoCenter for Lymphoid Malignancies, Department of Medicine and.
Owen A O'ConnorDivision of Hematology/Oncology, University of Virginia Comprehensive Cancer Center, Charlottesville, VA; and.
Marko JovanovicDepartment of Biological Sciences, Columbia University, New York, NY.
Changchun DengCenter for Lymphoid Malignancies, Department of Medicine and.
Luke E BerchowitzDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-3388-7723 Columbia University Irving Medical Center · USColumbia University · USUniversity of Virginia Cancer Center
Funding
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3MClinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0MElucidation of regulation and function of amyloid-like assembliesR35GM124633 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Luke E Berchowitz · 2017 to 2026
$4.2MRegulation of Protein Production Dynamics:RNA Binding Proteins and the Ribosome CodeR35GM128802 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI JOVANOVIC, MARKO · 2018 to 2022
$2.3MNCATS NIH HHS UL1 TR001873NCI NIH HHS P30 CA013696NIGMS NIH HHS R35 GM124633NIGMS NIH HHS R35 GM128802
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Casein Kinase IdeltaProtein Kinase InhibitorsProtein Processing, Post-TranslationalCasein Kinase IdeltaProtein Kinase Inhibitors
Identifiers
PMID35613464
PMCPMC9327539
OpenAlexW4281555941
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390